MLTX icon

MoonLake Immunotherapeutics

33 hedge funds and large institutions have $396M invested in MoonLake Immunotherapeutics in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

2.96% less ownership

Funds ownership: 99.8%96.84% (-3%)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

Holders
33
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$228M
2
$63.7M
3
$30.3M
4
$10.5M
5
$9.2M
6
$8.64M
7
$7.79M
8
$6.75M
9
$5.25M
10
$4.26M
11
$4M
12
$3.15M
13
$2.58M
14
$2.29M
15
$1.95M
16
$1.75M
17
$982K
18
$771K
19
$710K
20
$707K
21
$587K
22
$471K
23
$337K
24
$287K
25
$170K